wed similar control of fat malabsorption by spot fecal fat testing when switched to ZENPEP treatment at similar doses.
15 REFERENCES
Borowitz DS, Grand RJ, Durie PR, et al. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Journal of Pediatrics. 1995; 127: 681-684.
Borowitz DS, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. Journal of Pediatric Gastroenterology Nutrition. 2002 Sep; 35: 246-259.
Stallings VA, Start LJ, Robinson KA, et al. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. Journal of the American Dietetic Association. 2008; 108: 832-839.
Smyth RL, Ashby D, O’Hea U, et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.9 Lancet. 1995; 346: 1247-1251.
FitzSimmons SC, Burkhart GA, Borowitz DS, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. New England Journal of Medicine. 1997; 336: 1283-1289
16 HOW SUPPLIED/STORAGE AND HANDLING
ZENPEP® (pancrelipase) Delayed-Release Capsules
5,000 USP units of lipase; 17,000 USP units of protease; 27,000 units of amylase.
Each ZENPEP capsule is available as a two piece hypromellose capsule with white opaque cap and white body with a blue radial print and printed with “EURAND 5”, that contains 1.8-1.9mm enteric-coated beads. Capsules are supplied in bottles of:
12 capsules (NDC 42865-100-01)
100 capsules (NDC 42865-100-02)
ZENPEP® (pancrelipase) Delayed-Release Capsules
10,000 USP units of lipase; 34,000 units of protease; 55,000 units of amylase.
Each ZENPEP capsule is available as a two piece hypromellose capsule with yellow opaque cap and white body with a blue radial print and printed with “EURAND 10”, that contains 2.2-2.5mm enteric-coated beads. Capsules are supplied in bottles of:
12 capsules (NDC 42865-101-01)
100 capsules (NDC 42865-101-02)
ZENPEP® (pancrelipase) Delayed-Release Capsules
15,000 USP units of lipase; 51,000 units of protease; 82,000 units of amylase.
Each ZENPEP capsule is available as a two piece hypromellose capsule with red opaque cap and white body with a blue radial print and printed with “EURAND 15”, that contains 2.2-2.5mm enteric-coated beads. Capsules are supplied in bottles of:
12 capsules (NDC 42865-102-01)
100 capsules (NDC 42865-102-02)
ZENPEP® (pancrelipase) Delayed-Release Capsules
20,000 USP units of lipase; 68,000 units of protease; 109,000 units of amylase.
Each ZENPEP capsule is available as a two piece hypromellose capsule with green opaque cap and white body with a blue radial print and printed with “EURAND 20”, that contains 2.2-2.5mm enteric-coated beads. Capsules are supplied in bottles of:
12 capsules (NDC 42865-103-01)
100 capsules (NDC 42865-103-02)
500 capsules (NDC 42865-103-04)
Storage and Handling:
Avoid excessive heat. Store at room temperature (68-77°F; 20-25°C), brief excursions permitted to 15-40°C (59-104°F). Protect from moisture. AFTER OPENING, KEEP BOTTLE TIGHTLY CLOSED between uses to PROTECT FROM MOISTURE.
Dispense in tight container (USP).
Keep out of reach of children.